.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Healthtrust
Accenture
Farmers Insurance
Chubb
Daiichi Sankyo
Merck
Fuji
UBS
Express Scripts

Generated: June 24, 2017

DrugPatentWatch Database Preview

EPANED Drug Profile

« Back to Dashboard

What is the patent landscape for Epaned, and when can generic versions of Epaned launch?

Epaned is a drug marketed by Silvergate Pharms and is included in two NDAs. There are three patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in EPANED is enalapril maleate. There are twenty-seven drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the enalapril maleate profile page.

Summary for Tradename: EPANED

Patents:1
Applicants:1
NDAs:2
Suppliers / Packagers: see list1
Bulk Api Vendors: see list29
Patent Applications: see list5,008
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:EPANED at DailyMed

Pharmacology for Tradename: EPANED

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Silvergate Pharms
EPANED
enalapril maleate
SOLUTION;ORAL208686-001Sep 20, 2016RXNoNo9,669,008► SubscribeY ► Subscribe
Silvergate Pharms
EPANED KIT
enalapril maleate
FOR SOLUTION;ORAL204308-001Aug 13, 2013RXYesYes8,568,747► SubscribeY ► Subscribe
Silvergate Pharms
EPANED KIT
enalapril maleate
FOR SOLUTION;ORAL204308-001Aug 13, 2013RXYesYes8,778,366► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: EPANED

Drugname Dosage Strength RLD Submissiondate
enalapril maleate Powder for Oral Solution1 mg/mL Epaned Kit   6/21/2016
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Fuji
Teva
US Army
Queensland Health
UBS
Cipla
AstraZeneca
Cantor Fitzgerald
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot